as 05-14-2024 4:00pm EST
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
Founded: | N/A | Country: | N/A |
Employees: | 3261 | City: | N/A |
Market Cap: | N/A | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | N/A |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | N/A | EPS Growth: | N/A |
52 Week Low/High: | N/A | Next Earning Date: | N/A |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
SVA Breaking Stock News: Dive into SVA Ticker-Specific Updates for Smart Investing
Business Wire
15 days ago
Zacks
4 months ago
Business Wire
4 months ago
InvestorPlace
4 months ago
ACCESSWIRE
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago